High-cylinder toric IOL better for high astigmatism

Article

Cataract patients who have astigmatism of greater than 2.5 D are likely to benefit more from the implantation of a high-cylinder toric intraocular lens (IOL) than from the implantation of a low-cylinder toric IOL combined with limbal relaxing incision (LRI), according to research conducted at the Ouchi Eye Clinic and Kyoto Prefectural University of Medicine, Kyoto, Japan

Cataract patients who have astigmatism of greater than 2.5 D are likely to benefit more from the implantation of a high-cylinder toric intraocular lens (IOL) than from the implantation of a low-cylinder toric IOL combined with limbal relaxing incision (LRI), according to research conducted at the Ouchi Eye Clinic and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Fifty-seven eyes in 47 patients were studied. All of the eyes had preexisting corneal astigmatism of 2.5 D or greater. The eyes were divided into two treatment groups: One group (24 eyes) had a high-cylinder toric IOL (Alcon AcrySof IQ Toric T6, T7, T8 or T9) implanted. The other group (33 eyes) received the combination procedure of implantation of a low-cylinder toric IOL (Alcon Acrysof IQ Toric T5) and LRI. All of the procedures were performed by a single surgeon.

At 1 day postoperatively, patients in the group who received the high cylinder toric IOL had significantly better uncorrected visual acuity and significantly less manifest cylinder and refractive cylinder than patients who received the combination of a low-cylinder toric IOL and LRI. However, there was no significant difference in those parameters at 1 and 6 months postoperatively. The patients who received the combination low-cylinder IOL and LRI had significantly greater postoperative corneal and ocular higher-order aberrations.

"The findings of this study show that for the treatment of cataract patients with a high amount of astigmatism greater than 2.5 D, AcrySof IQ Toric T6, T7, T8 and T9 implantation can achieve better clinical outcomes, especially in the early postoperative period, than the combined procedure of AcrySof IQ Toric T5 implantation and LRI," the researcher reports.

The download the entire study, visit Clinical Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.